Pancreatic Cancer Research

ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years

Dalong Ni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6679-5414; OpenAlex author ID A5006097385. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Cerenkov radiation modulates the extracellular matrix for improved pancreatic cancer chemotherapy. Last author DOI 10.1016/j.celbio.2025.100221↗
  2. Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform. Co-author DOI 10.1002/smll.201907233↗
  3. 86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics. Co-author DOI 10.1021/acs.molpharmaceut.0c00127↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weibo Cai · 2 shared papers, 2020–2026 · strength 0.40
  2. Tao Wang · 1 shared paper, 2026 · strength 0.29
  3. Changjing Zuo · 1 shared paper, 2026 · strength 0.29
  4. Weiwei Su · 1 shared paper, 2026 · strength 0.29
  5. Yingying Xu · 1 shared paper, 2020 · strength 0.13
  6. Zhiguo Yu · 1 shared paper, 2020 · strength 0.13
  7. Jianlin Shi · 1 shared paper, 2020 · strength 0.13
  8. Dawei Jiang · 1 shared paper, 2020 · strength 0.11
  9. Carolina A. Ferreira · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.